HK1106502A1 - - Google Patents
Info
- Publication number
- HK1106502A1 HK1106502A1 HK07111220.2A HK07111220A HK1106502A1 HK 1106502 A1 HK1106502 A1 HK 1106502A1 HK 07111220 A HK07111220 A HK 07111220A HK 1106502 A1 HK1106502 A1 HK 1106502A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sub
- formula
- radical
- alkyl radicals
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0403873A FR2869034B1 (fr) | 2004-04-14 | 2004-04-14 | Derive du 14,15-dihydro 20,21-dinoreburnamenin 14-ol et leur utilisation pour le traitement des depressions |
PCT/FR2005/000902 WO2005103047A1 (fr) | 2004-04-14 | 2005-04-14 | Derives du 14.15-dihydro 20.21-dinoreburnamenin-14-ol, et leurs applications |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1106502A1 true HK1106502A1 (zh) | 2008-03-14 |
Family
ID=34944654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07111220.2A HK1106502A1 (zh) | 2004-04-14 | 2007-10-17 |
Country Status (12)
Country | Link |
---|---|
US (1) | US7354918B2 (zh) |
EP (1) | EP1737856B1 (zh) |
JP (1) | JP5156371B2 (zh) |
CN (1) | CN1953977B (zh) |
AT (1) | ATE488516T1 (zh) |
CA (1) | CA2563491A1 (zh) |
DE (1) | DE602005024788D1 (zh) |
ES (1) | ES2356657T3 (zh) |
FR (1) | FR2869034B1 (zh) |
HK (1) | HK1106502A1 (zh) |
IL (1) | IL178548A (zh) |
WO (1) | WO2005103047A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10918628B2 (en) | 2016-10-11 | 2021-02-16 | Deutsches Zentrum Für Neurodegenerative Erkrankungen E. V. (Dzne) | Treatment of synucleinopathies |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2081587B1 (zh) * | 1970-03-26 | 1973-04-06 | Anvar | |
BE797328R (en) * | 1971-08-31 | 1973-07-16 | Omnium Chimique Sa | Aminopropyl vincanols and eburnamines prepn - - by reaction of organo magnesium cpd with a vincanone or substd ebur |
FR2190113A5 (zh) * | 1972-06-19 | 1974-01-25 | Anvar | |
DE2538095A1 (de) * | 1974-09-06 | 1976-03-25 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
CH605949A5 (en) * | 1974-09-06 | 1978-10-13 | Sandoz Ag | Vincanol derivs |
FR2312245A1 (fr) * | 1975-05-26 | 1976-12-24 | Synthelabo | Nouveaux apovincamides, leurs sels, leur preparation et les medicaments qui en contiennent |
FI751840A (zh) * | 1974-09-24 | 1976-03-25 | Synthelabo | |
HU171163B (hu) * | 1974-09-27 | 1977-11-28 | Richter Gedeon Vegyeszet | Sposob poluchenija proizvodnykh trans eburnamenina |
CH612968A5 (en) * | 1975-06-03 | 1979-08-31 | Sandoz Ag | Process for the preparation of novel compounds from the vincanol-epivincanol group |
FR2381048A1 (fr) * | 1977-02-22 | 1978-09-15 | Roussel Uclaf | Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments |
FR2433528A2 (fr) | 1978-08-16 | 1980-03-14 | Roussel Uclaf | Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments |
FR2623503B1 (zh) * | 1987-11-19 | 1991-04-05 | Roussel Uclaf | |
FR2623501B1 (fr) * | 1987-11-19 | 1990-03-16 | Roussel Uclaf | Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
-
2004
- 2004-04-14 FR FR0403873A patent/FR2869034B1/fr not_active Expired - Fee Related
-
2005
- 2005-04-14 CN CN2005800158103A patent/CN1953977B/zh not_active Expired - Fee Related
- 2005-04-14 ES ES05757149T patent/ES2356657T3/es active Active
- 2005-04-14 JP JP2007507818A patent/JP5156371B2/ja not_active Expired - Fee Related
- 2005-04-14 AT AT05757149T patent/ATE488516T1/de not_active IP Right Cessation
- 2005-04-14 WO PCT/FR2005/000902 patent/WO2005103047A1/fr active Application Filing
- 2005-04-14 DE DE602005024788T patent/DE602005024788D1/de active Active
- 2005-04-14 CA CA002563491A patent/CA2563491A1/fr not_active Abandoned
- 2005-04-14 EP EP05757149A patent/EP1737856B1/fr not_active Not-in-force
-
2006
- 2006-10-13 US US11/581,950 patent/US7354918B2/en not_active Expired - Fee Related
- 2006-10-15 IL IL178548A patent/IL178548A/en not_active IP Right Cessation
-
2007
- 2007-10-17 HK HK07111220.2A patent/HK1106502A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20070088046A1 (en) | 2007-04-19 |
JP5156371B2 (ja) | 2013-03-06 |
CN1953977B (zh) | 2011-06-01 |
IL178548A (en) | 2010-12-30 |
US7354918B2 (en) | 2008-04-08 |
FR2869034A1 (fr) | 2005-10-21 |
DE602005024788D1 (de) | 2010-12-30 |
WO2005103047A1 (fr) | 2005-11-03 |
ES2356657T3 (es) | 2011-04-12 |
WO2005103047A8 (fr) | 2006-11-16 |
JP2007532612A (ja) | 2007-11-15 |
ATE488516T1 (de) | 2010-12-15 |
CA2563491A1 (fr) | 2005-11-03 |
FR2869034B1 (fr) | 2008-04-04 |
EP1737856B1 (fr) | 2010-11-17 |
IL178548A0 (en) | 2007-02-11 |
EP1737856A1 (fr) | 2007-01-03 |
CN1953977A (zh) | 2007-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP1753A (en) | Thiophene derivatives as antiviral agents for flavvivirus infection | |
DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
EA200500018A1 (ru) | Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения | |
DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
RS53627B1 (en) | N- (3-Amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors | |
BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
CY1106522T1 (el) | Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο | |
EA201101492A1 (ru) | Аналоги тиофена для лечения или предупреждения флавивирусных инфекций | |
AR052887A1 (es) | Derivados de tiazol, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para tratar enfermedades mediadas por la inhibicion de la protein quinasa | |
HRP20031098B1 (en) | Beta-amino tetrahydroimidazo (1,2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | |
RS50755B (sr) | Supstituisani aril i heteroaril derivati kao modulatori metabolizma i profilakse i lečenje poremećaja proisteklih iz toga | |
CO5700824A2 (es) | Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen | |
NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
MY129796A (en) | Novel anti-inflammatory androstane derivatives | |
MX2009003410A (es) | Fosfoindoles enantiomericamente puros como inhibidores de vih. | |
NO20071042L (no) | 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer | |
AR056321A1 (es) | COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS | |
NO20025641D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
DE602005022764D1 (de) | Piperidin- und azetidinderivate als glyt1-inhibitoren | |
AR049276A1 (es) | Compuestos carboxamidos opiodes y composiciones farmaceuticas que los contienen | |
WO2007039781A3 (en) | 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors | |
DK1485377T3 (da) | Pyranoner egnede som ATM-inhibitorer | |
NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
NO20050871L (no) | 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer |